High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial

Philip J. Clements*, Daniel E. Furst, Weng Kee Wong, Maureen Mayes, Barbara White, Fredrick Wigley, Michael H. Weisman, Walter Barr, Larry W. Moreland, Thomas A. Medsger, Virginia Steen, Richard W. Martin, David Collier, Arthur Weinstein, Edward Lally, John Varga, Steven Weiner, Brian Andrews, Micha Abeles, James R. Seibold

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

298 Scopus citations

Fingerprint

Dive into the research topics of 'High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science